ArticleJournal of cellular and molecular medicine2020

MiR-3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway.

Shiqi Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.